Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioRestorative Therapies Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BRTX
Nasdaq
8731
https://www.biorestorative.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioRestorative Therapies Inc
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
- Mar 11th, 2024 8:15 pm
Favourable Signals For BioRestorative Therapies: Numerous Insiders Acquired Stock
- Feb 15th, 2024 10:20 am
BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting
- Feb 14th, 2024 2:15 pm
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
- Feb 6th, 2024 1:05 pm
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
- Feb 5th, 2024 12:30 pm
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
- Feb 1st, 2024 12:30 pm
BioRestorative Therapies Receives a Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its Obesity Program
- Dec 12th, 2023 2:15 pm
11 Most Volatile Stocks Under $5 For Day Trading
- Dec 3rd, 2023 6:11 pm
BioRestorative Therapies, Inc. to Participate at the ROTH MKM Healthcare Opportunities Conference October 12, 2023 in New York City
- Oct 9th, 2023 4:10 pm
QIAGEN (QGEN) Extends the AI-Powered QCI Interpret Software
- Oct 2nd, 2023 1:14 pm
Roth MKM Analyst Projects An Impressive Price Target of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says “Low Valuation Undeserved”
- Sep 18th, 2023 1:00 pm
EXCLUSIVE: Stem Cell Focused BioRestorative Ventures Into $63B Aesthetics Market Via Supply Agreement With Evolutionary Biologics
- Sep 12th, 2023 2:30 pm
BioRestorative Therapies Enters into Supply Agreement with Evolutionary Biologics
- Sep 12th, 2023 1:00 pm
BioRestorative Therapies Announces Activation of Northwell Health in the Company's Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
- Sep 8th, 2023 12:30 pm
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
- Aug 30th, 2023 1:00 pm
Mirati (MRTX) Reports Q2 Loss, Misses Revenue Estimates
- Aug 8th, 2023 10:05 pm
BioRestorative Therapies Gains Additional Investor Confidence As Insider Dale Broadrick, CEO Lance Alstodt Purchase Thousands of Shares
- Aug 2nd, 2023 1:00 pm
Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion
- Jul 31st, 2023 12:05 pm
Insider Buying Alert: Lance Alstodt Acquires 4200 Shares of BioRestorative Therapies Inc (BRTX)
- Jul 26th, 2023 5:01 pm
BioRestorative Therapies (NASDAQ:BRTX) Receives Landmark License From New York State
- Jul 21st, 2023 11:10 am
Scroll